Bio-Implants Market Share, Size, Growth and Forecast 2023-2028

The latest report by IMARC Group, titled “Bio-Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global bio-implants market size reached US$ 117.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 189.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.12% during 2023-2028.

Bio-implants are bioengineered products used to replace, support, enhance, or regulate physiological functions. They are made from biosynthetic materials like collagen and tissue-engineered products such as artificial skin or tissues. They are categorized as biological implants, which encompass cell therapy, bioartificial organs, and tissue engineering; biologized implants, including in-vivo cell lining, technical implants, and biohybrid systems; and biofunctionalized implants, encompassing surface-functionalized implants and drug-eluting stents.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bio-implants-market/requestsample

Bio-Implants Market Trends and Drivers:

Owing to sedentary lifestyles, altering consumption patterns and inadequate nutritional intake among individuals, the prevalence of chronic conditions, such as osteoarthritis, and neuropathic, congenital and cardiovascular diseases, has increased which, in turn, is augmenting the demand for bio-implants worldwide. In addition, the geriatric population represents the biggest end user of bio-implants as elderly individuals are relatively more susceptible to coronary heart diseases, peripheral artery diseases and other age-related conditions. Apart from this, manufacturers are developing innovative prosthetics to reduce production costs and offer customized devices to patients. Further, due to the increasing beauty consciousness, along with the improving success rate of cosmetic surgeries, there has been a rise in the number of individuals seeking bio-implants for enhancing their physical appearance. Looking forward, the market to continue its moderate growth during the next five years.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type of Bio-Implants:

• Cardiovascular Implants
• Dental Implants
• Spinal Bio-implants
• Orthopaedic Implants
• Ophthalmic Implants
• Others

Breakup by Material:

• Metallic
• Ceramic
• Polymer
• Biological

Breakup by Origin:

• Allograft
• Autograft
• Xenograft
• Synthetic

Breakup by Mode of Administration:

• Non-Surgical
• Surgical

Breakup by End-User:

• Ambulatory Surgical Centers
• Clinics
• Hospital
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• Abbott Laboratories
• Boston Scientific Corporation
• Stryker Corporation
• St. Jude Medical Inc
• Medtronic Inc.
• Smith and Nephew
• Wright Medical Group
• Zimmer Biomet
• Dentsply Sirona
• Invibio Limited
• Straumann
• Danaher Corporation
• Cardinal Health
• Johnson & Johnson
• B. Braun Melsungen
• LifeNet Health, Inc
• Endo International plc.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal